Free Trial
NASDAQ:CYRX

CryoPort (CYRX) Stock Price, News & Analysis

CryoPort logo
$19.76 -0.13 (-0.63%)
Closing price 03:59 PM Eastern
Extended Trading
$19.82 +0.05 (+0.25%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About CryoPort Stock (NASDAQ:CYRX)

Advanced

Key Stats

Today's Range
$19.49
▼
$20.06
50-Day Range
$15.14
▼
$20.74
52-Week Range
$7.61
▼
$21.78
Volume
404,101 shs
Average Volume
661,618 shs
Market Capitalization
$1.00 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.69
Consensus Rating
Moderate Buy

Company Overview

Cryoport, Inc. provides temperature-controlled supply chain services for the life sciences industry. Its offerings support the development and commercial distribution of cell and gene therapies, biologics, reproductive medicine products and other temperature-sensitive materials.

The company’s services include specialized shipping systems and packaging, transportation management, cryogenic storage, shipment monitoring and logistics support. These solutions are designed to help customers maintain required conditions and manage the handling of sensitive materials across clinical and commercial supply chains.

Cryoport serves customers in North America, Europe and other international markets through its global network of facilities and logistics operations. The company has expanded its capabilities over time, including through acquisitions in cryogenic equipment and specialized logistics.

AI Generated. May Contain Errors.

CryoPort Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

CYRX MarketRank™: 
2.102717031145 of 5 stars

CryoPort scored higher than 42% of companies evaluated by MarketBeat, and ranked 658th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CryoPort has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 7 buy ratings, 2 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for CryoPort is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    CryoPort has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about CryoPort's stock forecast and price target.
  • Earnings Growth

    Earnings for CryoPort are expected to grow in the coming year, from ($0.88) to ($0.69) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CryoPort is -20.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CryoPort is -20.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CryoPort has a P/B Ratio of 2.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.59% of the float of CryoPort has been sold short.
  • Short Interest Ratio / Days to Cover

    CryoPort has a short interest ratio ("days to cover") of 4.14.
  • Change versus previous month

    Short interest in CryoPort has recently increased by 37.30%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    CryoPort does not currently pay a dividend.

  • Dividend Growth

    CryoPort does not have a long track record of dividend growth.

  • News Sentiment

    CryoPort has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for CryoPort this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, CryoPort insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,702,500.00 in company stock.

  • Percentage Held by Insiders

    9.50% of the stock of CryoPort is held by insiders.

  • Percentage Held by Institutions

    92.90% of the stock of CryoPort is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CryoPort's insider trading history.
Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CryoPort and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CYRX Stock News Headlines

KeyCorp Comments on CryoPort's FY2028 Earnings (NASDAQ:CYRX)
Cryoport (CYRX) Stock Looks Fully Priced Following Its 129% Rebound
Your Social Security check is scheduled for a 22% cut
The U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year. The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%. A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold.tc pixel
What Comes Next For Cryoport After A 100% Gain
Cryoport Needs To Chill Down (Downgrade)
See More Headlines

CYRX Stock Analysis - Frequently Asked Questions

CryoPort's stock was trading at $9.60 on January 1st, 2026. Since then, CYRX shares have increased by 105.9% and is now trading at $19.7650.

CryoPort, Inc. (NASDAQ:CYRX) announced its quarterly earnings data on Thursday, November, 5th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.18) by $0.07. The business had revenue of $50.22 million for the quarter, compared to analyst estimates of $48.66 million. CryoPort had a negative trailing twelve-month return on equity of 8.28% and a negative net margin of 21.46%.
Read the conference call transcript
.

Top institutional investors of CryoPort include First Eagle Investment Management LLC (2.51%), State Street Corp (2.11%), Assenagon Asset Management S.A. (1.84%) and Lionhunter Capital Management LLC (0.94%). Insiders that own company stock include Jerrell Shelton, Robert Stefanovich, Edward J Zecchini, Richard J Berman, Mark W Sawicki, Daniel M Hancock, Ramkumar Mandalam and Robert J Hariri.
View institutional ownership trends
.

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CryoPort investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Tesla (TSLA), Micron Technology (MU), Palantir Technologies (PLTR), Cisco Systems (CSCO) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/05/2026
Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:CYRX
CIK
1124524
Employees
738
Year Founded
1999

Price Target and Rating

High Price Target
$28.00
Low Price Target
$13.50
Potential Upside/Downside
+9.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$78.30 million
Net Margins
-21.46%
Pretax Margin
-18.25%
Return on Equity
-8.28%
Return on Assets
-4.88%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.04
Quick Ratio
1.94

Sales & Book Value

Annual Sales
$176.18 million
Price / Sales
5.70
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.19 per share
Price / Book
2.15

Miscellaneous

Outstanding Shares
50,700,000
Free Float
45,884,000
Market Cap
$1.00 billion
Optionable
Optionable
Beta
1.89

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:CYRX) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners